March 04, 2015 11:00 AM ET


Company Overview of Proteostasis Therapeutics, Inc.

Executive Profile

Mark J. Enyedy

Head of Corporate Development and Interim General Counsel, Shire plc
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships


Mr. Mark J. Enyedy has been Head of Corporate Development and Interim General Counsel at Shire plc since January 1, 2015. Mr. Enyedy joined Shire in 2013 and served as its Internal Medicine Business Unit Head from August 2013 to April 2014. Mr. Enyedy served as the Chief Executive Officer of Proteostasis Therapeutics, Inc. Mr. Enyedy joined Proteostasis after serving 15 years at Genzyme Corporation. He served as the President, Transplant, Oncology & Multiple Sclerosis ...

Corporate Headquarters

200 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-225-0096
Fax: 617-632-5739

Board Members Memberships

Former Chief Executive Officer and Director
Director, Chairman of Compensation Committee and Member of Audit Committee


Bachelor's Degree
Northeastern University
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
Haruo Naito Chief Executive Officer, Representative Corporate Officer and Director
Eisai Co., Ltd.
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proteostasis Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at